B lymphocytes and tertiary lymphoid structures have a prognostic impact on penile squamous cell carcinoma
The Journal of Pathology: Clinical Research · 2025-11 · 11 (6)
DOI: 10.1002/2056-4538.70059 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology: Clinical Research, online erschienen am 14.11.2025. Verfasst von Nicolette Zavillová und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, 3rd Faculty of Medicine of Charles University, Thomayer University Hospital, Prague, Czech Republic. Hauptthemen laut MEDLINE: Penile Neoplasms, Tertiary Lymphoid Structures, Carcinoma, Squamous Cell, B-Lymphocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Czech Republic, Conceptual Development of Research Organization, General University Hospital, Prague, Ministry of Health, Czech Republic, Conceptual Development of Research Organization Thomayer University Hospital, Agentura Pro Zdravotnický Výzkum České Republiky.
Abstract (Originalsprache)
Several prognostic markers, including tumor‐infiltrating lymphocytes, which have been recently identified in penile squamous cell carcinoma (pSCC), have focused mostly on T cells. The prognostic role of B cells and tertiary lymphoid structures (TLSs) has not yet been sufficiently described. We examined whole tissue sections histopathologically for TLSs and immunohistochemically for CD20 and CD138. The B‐cell immunoscore (B‐IS) divided the cohort into five categories based on the expression of these two B‐cell/plasma cell markers (CD20 and CD138, respectively). Patients with fewer TLSs had worse overall survival (OS) [hazard ratio (HR) = 2.17; 95% CI: 0.94–5; p = 0.069]. A significant association was identified between a high TLS diameter and the presence of a lymphocytic infiltrate [odds ratio (OR) = 2.2442; 95% CI: 1.1022–4.55; p = 0.0208]. Patients with low B‐IS (HR = 1.89, 95% CI: 1.18–3.03, p = 0.008), a low number of CD20 + cells in the tumor center (HR = 1.67, 95% CI: 1.04–2.7, p = 0.035), and a low number of CD20 + cells at the tumor invasion front (HR = 1.69, 95% CI: 1.06–2.78; p = 0.028) had significantly worse OS. High B‐ISs were strongly associated with a mutated p53 profile detected by immunohistochemistry (OR = 4.76, 95% CI: 1.32–25, p = 0.011), low T‐cell immunoscores (OR = 0.49; 95% CI: 0.23–1.03; p = 0.051), and brisk lymphocytic infiltration (OR = 2.0417, 95% CI: 1.01–4.76; p = 0.037). High CD20 + cell counts at the invasion front were associated with histological grade 3 disease (OR = 2.44, 95% CI 1.15–5.26, p = 0.015). An association was also observed between low B‐IS and mutations in KMT2D (OR 0.31, 95% CI: 0.07–1.21, p = 0.057) and EGFR (OR = ∞, 95% CI: 0.86–∞, p = 0.053). In conclusion, high numbers of tumor‐infiltrating B cells within TLSs represent a favorable prognostic marker in pSCC. These findings emphasize the need to identify novel microscopic prognostic markers during pathological assessment to guide early and appropriate therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, 3rd Faculty of Medicine of Charles University, Thomayer University Hospital, Prague, Czech Republic.
- Department of Anesthesia and Intensive Care Medicine, 3rd Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
- Department of Pathology, 1st Faculty of Medicine, Charles University, General University Hospital, Prague, Czech Republic.
- Department of Urology, 3rd Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
- Department of Pathology, 3rd Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
- Department of Pathology and Molecular Medicine, 3rd Faculty of Medicine, Charles University, Thomayer University Hospital, Prague, Czech Republic.
ORCID-Profile: Petr Waldauf, Michaela Kendall Bártů, Jan Hojný, Radoslav Matěj, Roman Zachoval, Jan Hrudka
Förderung
- Ministry of Health, Czech Republic, Conceptual Development of Research Organization, General University Hospital, Prague
- Ministry of Health, Czech Republic, Conceptual Development of Research Organization Thomayer University Hospital
- Agentura Pro Zdravotnický Výzkum České Republiky
- The Charles University program Cooperatio
- Ministry of Health – Kingdom of Saudi Arabia
Zitieren
APA
Zavillová, N., Waldauf, P., Kendall Bártů, M., Čapka, D., Hojný, J., Prouzová, Z., Matěj, R., Zachoval, R., & Hrudka, J. (2025). B lymphocytes and tertiary lymphoid structures have a prognostic impact on penile squamous cell carcinoma. The Journal of Pathology: Clinical Research, 11(6). https://doi.org/10.1002/2056-4538.70059
Vancouver
Zavillová N, Waldauf P, Kendall Bártů M, Čapka D, Hojný J, Prouzová Z, et al. B lymphocytes and tertiary lymphoid structures have a prognostic impact on penile squamous cell carcinoma. The Journal of Pathology: Clinical Research. 2025;11(6). doi:10.1002/2056-4538.70059
BibTeX
@article{Zavillov2025,
author = {Zavillová, Nicolette and Waldauf, Petr and Kendall Bártů, Michaela and Čapka, David and Hojný, Jan and Prouzová, Zuzana and Matěj, Radoslav and Zachoval, Roman and Hrudka, Jan},
title = {B lymphocytes and tertiary lymphoid structures have a prognostic impact on penile squamous cell carcinoma},
journal = {The Journal of Pathology: Clinical Research},
year = {2025},
volume = {11},
number = {6},
doi = {10.1002/2056-4538.70059}
}
EUVIMED